Inventor
WRIGHT JIM A
CA13 patents
⚠️ This page may combine multiple inventors who share the name “WRIGHT JIM A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENESENSE TECHNOLOGIES INC
8 patentsUS6121000ASep 19, 2000
Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
GENESENSE TECHNOLOGIES INC62 citations94
US6566514B1May 20, 2003
Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
GENESENSE TECHNOLOGIES INC16 citations82
US6593305B1Jul 15, 2003
Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
GENESENSE TECHNOLOGIES INC11 citations72
US6417169B1Jul 9, 2002
Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to inhibit cell growth
GENESENSE TECHNOLOGIES INC7 citations71
US7087580B2Aug 8, 2006
Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
GENESENSE TECHNOLOGIES INC4 citations60
US6610539B1Aug 26, 2003
Antisense oligonucleotide sequences as inhibitors of microorganisms
GENESENSE TECHNOLOGIES INC3 citations58
US7223849B1May 29, 2007
Oligonucleotides from the untranslated regions of housekeeping genes and methods of using same to modulate cell growth
GENESENSE TECHNOLOGIES INC0 citations51
US6472376B2Oct 29, 2002
Suppression of malignancy utilizing ribonucleotide reductase R1
GENESENSE TECHNOLOGIES INC0 citations51
LORUS THERAPEUTICS INC
2 patentsUS7405205B2Jul 29, 2008
Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
LORUS THERAPEUTICS INC4 citations61
US7968526B2Jun 28, 2011
Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer
LORUS THERAPEUTICS INC1 citations51